AGL:NYE-agilon health Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 5

Change

-0.13 (-2.53)%

Market Cap

USD 2.11B

Volume

2.41M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-5.03 (-1.60%)

USD 80.70B
UHS Universal Health Services Inc

-0.03 (-0.02%)

USD 11.68B
DVA DaVita HealthCare Partners Inc

-1.84 (-1.34%)

USD 11.67B
FMS Fresenius Medical Care Corpora..

+0.57 (+2.83%)

USD 11.00B
THC Tenet Healthcare Corporation

-1.23 (-0.99%)

USD 10.22B
CHE Chemed Corp

-7.65 (-1.32%)

USD 9.53B
EHC Encompass Health Corp

-0.59 (-0.69%)

USD 8.26B
SEM Select Medical Holdings

+0.11 (+0.34%)

USD 3.87B
AMN AMN Healthcare Services Inc

+0.08 (+0.13%)

USD 2.28B
USPH US Physicalrapy Inc

-1.67 (-1.58%)

USD 1.60B

ETFs Containing AGL

LSEQ Harbor Long-Short Equity .. 3.74 % 0.00 %

-0.19 (-0.71%)

USD 0.01B
MVE:AU VanEck Vectors Australian.. 0.00 % 0.00 %

+0.31 (+-0.71%)

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -60.16% 9% A- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.16% 9% A- 1% F
Trailing 12 Months  
Capital Gain -79.40% 9% A- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -79.40% 9% A- 1% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -17.13% 13% F 5% F
Dividend Return -17.13% 13% F 5% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.63% 83% B 42% F
Risk Adjusted Return -64.34% 13% F 5% F
Market Capitalization 2.11B 63% D 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector